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2ABSTRACT
Extensive diversity (genetic, cytogenetic, epigenetic and phenotypic) exists within and 
between tumors, but reasons behind these variations, as well as their consistent hierarchical 
pattern between organs, are poorly understood at the moment. We argue that these phenomena 
are, at least partially, explanable by the evolutionary ecology of organs’ theory, in the same 
way that environmental adversity shapes mutation rates and level of polymophism in 
organisms. Organs in organisms can be considered as specialized ecosystems that are, for 
ecological and evolutionary reasons, more or less efficient at supressing tumours.  When a 
malignancy does arise in an organ applying strong selection pressure on tumours, its 
constituent cells are expected to display a large range of possible surviving strategies, from 
hyper mutator phenotypes relying on bet-hedging to persist (high mutation rates and high 
diversity), to few poorly variable variants that become invisible to natural defences. In 
contrast, when tumour suppression is weaker, selective pressure favouring extreme surviving 
strategies is relaxed, and tumours are moderately variable as a result. We provide a 
comprehensive overview of this hypothesis.
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3Extensive genetic, cytogenetic and epigenetic variation, as well as phenotypic diversity exist 
between and within tumors (i.e. inter- and intratumour heterogeneity respectively, the latter 
being called ITH thereafter) [1] [2] [3] [4]. Three main types of stochastic phenomena leading 
to ITH can be distinguished. The most well-known and by far most studied is genetic 
variability resulting from mutational processes [5]; a more recent but also intensively studied 
field is epigenetic variability [6]; and finally the most largely unexplored is gene expression 
variability [7]. The implications and clinical importance of these different sources of ITH are 
considerable since ITH may underlie incomplete treatment responses, acquired and/or innate 
resistance, and disease relapse in response to chemotherapy and targeted agents [8] [9] [10] 
[11] [12]. Because ITH is an important clinical determinant of patient outcomes, its origins 
have been the subject of much discussion by investigators. While genomic instability seems to 
be the major proximate process generating ITH [13], no consensus has however emerged 
between the several (non-mutually exclusive) hypotheses proposed to explain its 
establishment and maintenance [14] [15] (Box 1). Interestingly, several studies have also 
highlighted that both mutational processes and ITH between cancer types display a relatively 
constant hierarchical pattern between organs, with for instance melanoma and lung cancers 
being on average the most heterogenous cancers [16] [17] [18] [19]. Despite extensive 
research, the processes behind this hierarchy remain unclear as well. 
In this paper, we propose that variation in mutational patterns and ITH result from the 
evolutionary ecology of organs’ theory [20], and are therefore explained by the same rules 
than those governing mutational patterns and polymorphism in organisms living in more or 
less adverse habitats [21] [22]. For instance, genomic diversity is generally positively 
correlated with abiotic and biotic stress levels (e.g. [23] [21] [24] ), leading sometimes to the 
selection of hyper-mutator phenotypes [25] [26]. Beyond a high-threshold level of stress, the 
D
ow
nloaded from
 https://academ
ic.oup.com
/em
ph/advance-article-abstract/doi/10.1093/em
ph/eoz017/5512491 by U
FR
 M
ATH
EM
ATIQ
U
ES PU
R
ES APPL. BIBLIO
TH
EQ
U
E M
M
E D
O
C
LO
T BATIM
EN
T M
2 VILLEN
EU
VE D
'ASC
Q
 59655 FR
AN
C
E user on 09 August 2019
4diversity may also sometimes decline to a few adapted genotypes potentially displaying 
strong evolutionary convergence [27] [28]. Organs in organisms can be considered as 
specialized ecosystems in a living landscape, whose ecologies are more or less favourable to 
cancer progression. The evolutionary ecology of organs’ theory predicts that the evolution of 
organ specific resistance to malignant emergence and/or progression should be governed by 
their level of exposure to oncogenic factors together with the host’s evolutionary responses in 
relation with the direct or indirect fitness importance of each organ [20]. Here, assumming 
that the number of mutations typically found in a cancer is an indicator of the diversity of 
molecular characteristics of cancer cells, we discuss the extent to which this hypothesis could 
explain inter organ variability in mutational and ITH hierarchy patterns, as well as examine 
whether it could explain the predilection for metastatic site(s) by different cancer types.
The local selective filter hypothesis
Recently, Vittecoq et al. [29] argued that a promising research direction for discovering novel 
anticancer therapies consist in exploring cancer suppressive mechanisms in animals living in 
environments that favour cancer emergence and/or progression. Indeed, the same way as the 
lack of correlation between body size/life expectancy and cancer incidence led to Peto’s 
paradox [30], a lack of correlation between exposure to oncogenic factors and cancer 
incidence might suggest that evolution has produced solutions to avoid and/or control 
malignant problems in those species. From an evolutionary perspective, a similar conceptual 
framework can be applied at the organs’ level [31] [32]. Concretely, we expect that selection 
has locally shaped powerful natural defences against malignant emergence/progression, and 
hence mostly aggressive neoplasms (i.e. higher mutational and ITH levels), or conversely few 
invisible ones succeed in emerging and developing in organs strongly exposed to mutagenic 
substances. In contrast, organs that are less exposed to oncogenic factors have been less 
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5optimised by selection to be efficient at controlling malignant developments, and as a result, 
less aggressive neoplasms (i.e. lower mutational and ITH levels) may regularly emerge and 
progress in these tissues. These predictions seem in accordance with the hierarchical patterns 
observed for both mutational processes and ITH.  Indeed, skin, lung or the digestive tract are, 
all thinghs being equal, for instance undoubtedly more exposed to mutagenic substances than 
breast, pancreas or thyroid [33] [34] [35]. This phenomenon is of course exacerbated in our 
modern world [36]. Similarly, differential exposures to injuries and/or to infections, which 
can promote secondarily carcinogenesis, exists between organs [37]. 
Following the same idea, it has been long accepted in evolutionary immunology that 
strong immunological defences are also costly at the organ and tissue levels in terms of 
oxidative damage, since increased level of reactive oxygen species (ROS) is a by-product of 
elevated metabolism associated with an immune response, but also a defence mechanism used 
by immune cells [38] [39]. The level of these oxidative costs (or the strength of protection 
against these costs) can be organ-specific, as has been demonstrated in several studies on wild 
animals (e.g. [40] [41]). Accordingly, organs that are more efficient at controlling early-stage 
malignant emergence at the level of immune responses could be more vulnerable to tumor-
promoting inflammation and mutations caused by ROS on the genomic level, resulting in 
higher ITH of neoplasms in these organs. Thus, tumor-promoting inflammation and antitumor 
immunity coexist at different points along the path of tumor progression, and environmental 
and microenvironmental conditions should dictate the balance between the two [42].
Carcinogenesis also typically occurs within the spatial constraints of the epithelial 
layer of the organ. In the breast and pancreas, for example, this involves tumour growth 
within a narrow duct while in the colon, premalignant lesions (e.g. polyps) grow into the 
lumen of the bowel and on the skin. The cell-cell interaction network is another factor that 
could explain the differential sensitivy of organs and tissues to neoplasm development. 
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6Indeed, it could be a major contributor among the cancer suppressive mechanisms in animals. 
When examining the connectivity of 144 cell types in terms of ligands and receptors, recent 
works found that hematopoietic lineages are outliers because thay are far less connected than 
all other cell types [43]. These lineages are also known to be the less mutated [43] and seem 
to not necessitate strong genetic instability, suggesting that a major suppressive force might 
be situated at the level of the cell-cell interaction network. Nevertheless, apart from blood 
cancers, brain cancers such as glioma can also be characterized by low mutational load. 
Interestingly, gliomas are also the ones with the highest ITH among solid tumors [19], 
suggesting that the low mutational load in these cases is compensated by high ITH. As 
previously discussed (Box 2), if tissue disruption is an initiator event in oncogenesis [44] [45], 
a strong and dense cell-cell-interaction network is expected to more efficiently prevent 
malignant development. Thus, the more cells are connected in a tissue or an organ, higher 
ITH is necessary for oncogenesis to occur, at least during the first steps of tumorigenesis. On 
the contrary, less connected tissues are expected to contribute to cancer types with the lowest 
ITH levels. Interestingly, works in ecology revealed a correlation between the connectivity 
between species in an ecosystem and the resistance to invaders [46], suggesting again that 
homology between species in ecological niches and cell types in organs could be relevant.
The local selective filter hypothesis not only provides an explanation for the different 
levels of mutations and ITH observed between cancer types and organs, but also support the 
fact that cancer could initiate when this selective filter at the tissue and organ levels is broken 
down. Interestingly, genes linked to multicellularity are systematically repressed in solid 
cancers while those that are more associated with unicellularity are upregulated [47]. This 
observation, which is concordant with the atavism hypothesis [48] [49], suggests that cancer 
cells transit to a more “selfish” unicellular mode of life through an active and directed process 
driven by selection [48]. Especially, genes linked to the extracellular matrix and adhesion as 
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7well as signaling and cell communication are mostly dowregulated. Among the 7 cancer types 
studied, those (breast and prostate) that have the most similar expression profile of 
multicellularity associated genes to normal tissue are also the least mutated [50], suggesting 
again that the level of genetic instability could be dependent on the need to break down the 
network of dense cellular interactions. 
Finally, the nature and frequency of cancer stem cells are still a controversial debate. 
Inconsistencies in the numbers of such cells reported in the literature can be a consequence of 
the different definitions used by researchers. As suggested below (Box 2), oncogenesis could 
result from tissue disruption that generates differentiation problems because of the lack of 
tissue control42,43. In our opinion, cancer stem cells have to be considered as cells acquiring 
highly unstable and variable phenotypes similar the ones of normal stem cells (due to high 
gene expression noise), but without the normal control normally exerted by the 
microenvironment.  
If cancer development depends especially on the ability to counteract the cell-cell 
interaction network, it could be assumed that dedifferentiation (from differentiated cells) or 
failure of differentiation (from adult stem cells) are the best way to generate cells that are no 
more submitted to microenvironmental control because of the intrinsic plasticity and 
instability of such cancer stem-like cells[44] [51]. Consequently, the more cells of a tissue are 
under the control of their environment, the more they would need to acquire stem-cell like 
properties (and in higher number) to overcome this local selective filter. Tumors in tissues 
with stronger local selective filter would logically contain more cells with such unstable 
phenotypes. Thus this framework could explain the differences in the frequency of cancer 
stem cells between tumors. As these cells are themselves a source of phenotypic 
heterogeneity, this would be also associated to higher non-genetic ITH in these tumors. 
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8Metastatic predilection site
Due to higher mutation rates, cancerous cell communities originating from neoplasias in 
organs with high resistance to malignant emergence should be able to produce metastases in a 
wider variety of organs compared to less diverse tumour cell communities. The understanding 
that metastasis results when tumour cells interact with a specific organ’s microenvironment 
stems from the “seed and soil" hypothesis, stating that certain tumour cells (‘seed’) have 
specific affinity for the milieu of certain organs (‘soil’), and metastases form only when the 
seed and soil are compatible [52] [53]. Although this hypothesis has been one of the most 
persistent in the study of cancer, and supported by a wide range of experimental evidence 
[53], it has not been linked to the mutation and ITH patterns. At the same time, it is logical to 
assume that the most lethal metastatic "seeds" evolve as a result of selective pressure in the 
primary tumor [54], and the selective pressure assumed to be the highest in organs that are 
most protected against malignant developments.
For example, while melanoma (rated highest on mutational processes by [50] and 2nd 
by [17]) cells introduced in mouse circulation can cause tumor development in a wide variety 
of tissue types[55], human ovarian cancer (ranked 14th at ITH by [50] and 19th by [17]) cells, 
despite continuous entry of millions of tumour cells into the circulation, rarely cause 
metastases even to the lung, the first capillary bed encountered [56]. Similarly, prostate cancer 
(ranked 15th by [50] and 21st by [17]) “seeds” have a very low probabilty to find a compatible 
“soil” in any tissues, but colorectal cancer (1st by [17], 7th by [50]) “seeds” readily give 
metastasis in a number of organs, exhibiting a cascadic spread of gastro-intestinal tumors, 
where metastases in secondary sites spread “seeds” to the organs that follow the blood drain 
route [57].
Concluding remarks
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9We only see cancers that succeed in their development and this fraction corresponds to 
malignancies that bypass our natural defences. As soon as defences are unequal between the 
different parts of the body, the fraction of successful cancers is also expected to vary 
accordingly. By suggesting that the efficency of natural defenses against cancer development 
is organ-specific and that it explains the hierarchy in mutation load and ITH between organs, 
our hypothesis highlights the role of the cellular environment in shaping the tumoral genomic 
and epigenomic content. In standard models of cancer, the cellular environment is destroyed 
as a consequence of cancer progression, thus has also a passive role and no driver role in 
tumor evolution. On the contrary, our hypothesis considers that the level of diversity needed 
for cancer development is precisely dependent on and the consequence of the ability of an 
organ to suppress this development. It contributes to the continuously growing body of works 
that place major influences in oncogenesis at higher levels of organization than the genomic 
level while not denying the major contribution of genetic and epigenetic instability in cancer 
progression. 
An evolutionary theory needs to consider more than just humans, and needs to consider 
"historical" cancer patterns that would be more in line with the selective pressure experienced 
by our ancestors (which largely determined our genetic makeup and tumour suppressive 
strategies). While historical cancer data are undoubtedly difficult to find, we encourage 
scientists to explore our hypothesis using different datasets among various animal species. We 
also encourage researchers to perform experimental studies specifically designed to test 
whether cells with high mutation rate are, as proposed here, more likely to metastasize than 
others.
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BOX 1- Current hypotheses for the establishment and the maintenance of different 
types of intratumour heterogeneity (ITH)
Several non-mutually exclusive models have been recently published to explain the 
establishment and maintenance of ITH. For certain cancer/organ combination, it has been 
argued that a significant proportion of somatic mutations result from exposures to mutagens, 
e.g. ultraviolet light in skin cancers, or tobacco smoking in lung cancers [58]. While this 
process undoubtedly contributes to generate ITH, it cannot account, alone, for the extreme 
ITH values frequently observed in certain organs, especially in tiny tumors (e.g. [59]). 
Waclaw et al. [60] proposed a model for tumour evolution suggesting that cell turnover 
together with short-range migration can account for rapid cell mixing within the tumour. 
Alternatively, according to the cancer stem cell hypothesis, ITH results from the 
differentiation of few cells with stem cell properties (e.g. unrestricted self-renewal abilities) 
that produce various cell types in the tumour [61]. In parallel, the linear clonal evolution 
hypothesis suggests that ITH is due to the accumulation of various hereditary changes over 
time that confer selective advantages to some premalignant and malignant cells [62]. Finally, 
the plasticity cell hypothesis postulates that the majority of tumour cells, depending on 
microenvironmental conditions and/or cell intrinsic stochasticity, display varying degrees of 
stem cell–like characteristics [14]. In accordance with this idea, Lloyd et al. [63] suggested 
that (at least some) intratumour heterogeneity in the molecular properties of cancer cells is 
governed by predictable regional variations in environmental selection forces. In fact, a 
common point in these hypotheses is to argue that because ITH plays a crucial role in 
neoplasia, cancer progression and therapeutic resistance, its persistence, once initiated, is 
supported by various selective costs and benefits. Although realistic in many cases, this 
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hypothesis has however some limitations because environments change unpredictably and 
evolution cannot anticipate the future. It is therefore challenging to explain the occurrence of 
ITH at the very first steps of the tumorigenesis. Genetic ITH can be so extreme even in tiny 
tumors, that Ling et al. [59] recently argued that evolution under a “non-Darwinian mode” is 
plausible, because genetic diversity observed would be orders of magnitude lower than 
predicted by simple classic Darwinian selection. 
Recently, Thomas et al. [15] argued that generative mechanisms of ITH could also 
provide selective advantages to cells from the first steps of oncogenesis. In this hypothesis, 
malignant cells achieve greater success by cooperating in the process of tumour construction, 
providing the other with a common good, rather than by just being proliferative in isolation. 
There would be a concomitant selection of a bet-hedging strategy during oncogenesis, and 
hence ITH, because this is necessary to generate the diversity of cell components needed to 
build, de novo, a novel and an intricate cooperative system like the solid tumor is. 
Finally, the molecular heterogeneity within tumours could be fundamentally driven by 
variations in spatial and temporal distribution of blood flow (see for instance [64] [65]), 
suggesting that variations in patterns of angiogenesis in different organs could be the primary 
driver of molecular heterogeneity.
BOX 2- ITH on the level of gene expression
Apart from genetic ITH, high heterogeneity in gene expression is observed within 
cancers [7], even at the single-cell level [66]. Cancer cells harbour a continuum of 
heterogeneous phenotype states demarcated by gradients of marker expression rather than 
distinct subpopulations [67]. An early increase in non-genetic ITH, especially in gene 
expression variability from cell-to-cell, has been suggested to account for phenotypic 
diversification in early steps and ultimately to oncogenesis [44]. Indeed, gene expression 
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variability is modulated during development and differentiation and many studies showed that 
following a phase of highly stochastic and widespread gene expression, cells progressively 
transit towards a more homogeneous, coordinated and restricted gene expression pattern [68] 
[69] [70]. Cellular interactions are major determinants in constraining and decreasing gene 
expression variability and seem to be the main “constraints” leading to these stable 
differentiated states [71] [72]. For instance, direct cell contacts through gap junctions spatially 
coordinate prolactin gene expression in pituitary adult tissue [73]. Moreover, enzymatic 
digestion of extracellular proteins or pharmacological inhibition of gap junctions reduced 
transcriptional coordination between cells [73], showing that perturbation of cell 
communication can enhance gene expression variability and phenotypic heterogeneity among 
differentiated cells. 
Thus, tissue disruption could be the initial source of gene expression ITH [44] 43 and 
genetic instability has been proposed to be caused by this early gene expression ITH 49. In 
accordance with this hypothesis, numerous studies have now shown that tissue disruption can 
be either the inducer or the repressor of the cancerous state [44] 70 71 72 73. Therefore, the 
presence of epigenetic 74, gene expression 75, or micro-environmental 76 alterations that might 
precede the emergence of genetically abnormal cells further argues for a major role of non-
genetic processes in the first steps of oncogenesis. 
The early increase in gene expression variability allows another type of bet-hedging that 
can synergize with genetic ITH to allow phenotypic diversification, the transcriptional ITH. 
When RNA-seq data were used to measure the level of transcriptional ITH, 12 major cancer 
types showed distinct levels of this type of ITH [7]. Interestingly, when these results were 
compared with previous data on genetic ITH, a positive correlation between genetic 
heterogeneity and transcriptional ITH was found  [7].  Both types of ITH can thus be 
considered as relevant forces in a bet-hedging strategy where the level of heterogeneity would 
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be dependent on the level of cooperation needed in the process of tumor construction to 
bypass suppressive forces in tissues.
Finally epigenetic alterations are also increasingly acknowledged as being able to 
initiate transformation, as genetic alterations do, by providing the gene expression plasticity 
necessary to provide stochastic oncogenic epigenetic changes 77. Epigenetic instability can 
also allow phenotypic diversification in the bet-hedging strategy that we proposed here in the 
early steps of oncogenesis. Interestingly, while the global levels of genetic and epigenetic 
variations between tumour types are mostly uncorrelated 78, when epigenetic and genetic ITH 
were measured by analysis of DNA methylation and copy number alterations in aggressive 
prostate cancer, the structure of phylogenetic trees constructed from the epigenetic and 
genetic data were very close, indicating a similarity in evolutionary process 79. Other works 
revealed such correlation [6]: for instance, the level of DNA methylation ITH within an 
individual's leukaemia was positively correlated with the level of genetic ITH 80. Landau et al 
81 also found this correlation in chronic lymphocytic leukaemia between high numbers of sub-
clonal mutations and high DNA methylation ITH. Finally, this correlation between genetic 
and epigenetic heterogeneity was completed in this last work by an additional correlation 
identified with data from single-cell RNA sequencing: promoters with high methylation ITH 
showed high cell-to-cell expression heterogeneity of the corresponding gene 81. Altogether 
these works reveal that genetic, epigenetic, and gene expression ITH are mostly correlated 
and suggest that different levels of all these types of ITH, and thus different levels of bet-
hedging, are needed depending on the tissue and organ considered. However, despite a 
diversity of hypotheses that explain why ITH is omnipresent, the reasons governing these 
different levels of ITH are still unclear. 
D
ow
nloaded from
 https://academ
ic.oup.com
/em
ph/advance-article-abstract/doi/10.1093/em
ph/eoz017/5512491 by U
FR
 M
ATH
EM
ATIQ
U
ES PU
R
ES APPL. BIBLIO
TH
EQ
U
E M
M
E D
O
C
LO
T BATIM
EN
T M
2 VILLEN
EU
VE D
'ASC
Q
 59655 FR
AN
C
E user on 09 August 2019
